Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Rumpl3StiltSkinon Aug 26, 2021 9:15am
245 Views
Post# 33766562

RE:RE:RE:RE:The delayed newsletter

RE:RE:RE:RE:The delayed newsletterI do agree and normally I'd be just as frustrated, but isn't TLT now under Li Ka Shing's wing? Wont this get out to the world through his institute, assuming the data %s improve for NMIBC? Screw the FDA and their corruption if they stymie this tech, or try. ;-)

Yajne wrote: Amen CAinPlap, it's a similar concern that I have posted several times over the past years! ...and the pharma with much revenue at risk is wise in how they deploy the roadblocks...many medical/regulatory folks in high positions on the dole, directly or indirectly (disguised). Like you said, too many billions at risk for some of the 'pill pushers' to simply sit back and watch. The will spend a few million here and there to protect many billions, that's for sure!
CAinPlap wrote: Now I'm curious as to what company that was from.
It is that sentiment (profits first, humanity second at best) that has always made me wonder how many hurdles will be put in our path. If my overly simplistic view is correct that if/when this works on bladder cancer, it is only a matter of tweaking the pdt delivery and light delivery to other cancers, then I suspect there will be no punches pulled by Big pharma in protecting there existing billions in annual revenue from existing treatments. Even delaying a cure for a few months/years is worth huge dollars.   




<< Previous
Bullboard Posts
Next >>